International Faculty

	Dr. Flora Payvandi Director, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti Università degli Studi di Milano Milan, Italy View Profile
Who will speak on what !
1. Thrombotic thrombocytopenic purpura - Advances 2. Hemophilia : Diagnosis, treatment and complications - The past and future 3. Bleeding disorders - Advances in treatment
	Dr. Sabina Eichinger Professor of Medicine Department of Internal medicine Medical University of Vienna Karl Landsteiner Institute of Thrombosis Research, Vienna, Austria View Profile
Who will speak on what !
1. All about DOACs 2. Recurrent DVT - All that a clinician should know 3. Cancer related thrombosis
	Dr. Henrik Hasle Professor Department of Paediatrics, Aarhus University Hospital Skejby, Aarhus, Denmark View Profile
Who will speak on what !
1. Myelodysplastic and Myeloproliferative Disorders of Childhood 2. Management of childhood AML 3. Late complications in survivors of AML
	Dr. Ajay Nooka Assistant Professor Division of Bone Marrow Transplant Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA
Who will speak on what !
1. Definition and management of high risk myeloma: progress in the last decade 2. Newer Therapeutic options for R/R myeloma: focus on Carfilzomib 3. ASH 2016 updates in myeloma
	Dr. Naval Daver Assistant Professor Leukemia Department MD Anderson Cancer Center Houston, Tx, USA View Profile
Who will speak on what !
1. A Look at Immunotherapeutic Drug Development in leukemia and MDS: 2017 2. AML: Highlights of Molecular and Immune Therapies from ASH 2016 3. The future of Hypomethylating Agents in AML: Building Optimal Combinations
	Dr. Ghulam Mufti Director of King's College Hospital NHS Foundation Trust Professor of Haemato-oncology, Clinical Director of Pathology Head of the Department of Haematology King's College Hospital, London, UK
Who will speak on what !
1. Low risk MDS - What is new ? 2. High risk MDS - What is new ? 3. Pathobiology of MDS - What is new ?
	Dr. John Mascarenhas Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA View Profile
Who will speak on what !
1. Ruxolitinib the past, present and what to expect in the future 2. Case based clinical approach to modern management of ET, PV and PMF, as well as MPN related AML 3. Updates on MPN from ASH 2016
	Dr. A C Newland Professor Department of Haematology Barts Health NHS trust - The Royal London Hospital London, UK
Who will speak on what !
1. How do I treat ITP in 2017 ? 2. A to Z about Romiplostim in the treatment of ITP 3. Platelets : What was new in ASH-2016 ?
	Dr Neal Young, MD Senior Investigator Cell Biology Section, Hematology Branch National Heart, Lung and Blood Institute National Institutes of Health, Bethesda, MD, USA View Profile
Who will speak on what !
1. Immunology of acquired aplastic anemia: pathophysiology and treatment 2. Telomere disease and other constitutional marrow failure syndromes in adults 3. Eltrombopag as stem cell stimulation in bone marrow failure
	Dr Genoveffa Franchini, MD Center for Cancer Research National Cancer Institute (NCI) National Institutes of Health Bethesda, MD, USA View Profile
Who will speak on what !
1. From animal studies to men and back: Prospective in the development of a vaccine for HIV
	Dr Mala K Talekar, MD Attending Physician, Cancer Immunotherapy Frontier Program Division of Oncology & Blood and Marrow Transplantation Department of Pediatrics The Children’s Hospital of Philadelphia, Philadelphia, USA View Profile
Who will speak on what !
1. Chimeric Antigen Receptor (CAR) Modified T cell Therapy for relapsed / refractory pediatric leukaemias